Organization & Developments: Linshom

Parents

*Eliminates the morbidity, mortality and cost due to unrecognized respiratory compromise in healthcare with the first PREDICTIVE respiratory device vs. the current RESPONSIVE systems used today.
*Linshom (“to breathe”) is first to deliver continuous predictive respiratory monitoring to the patient bedside and home.
*Linshom (“to breathe”) Medical is first to deliver an Operating Room quality respiratory profile to the patient bedside (or home) for continuous, predictive respiratory monitoring (CPRM).
*Patented and FDA cleared sensor provides a predictive (vs. responsive) respiratory profile including Respiratory Rate (RR), relative Tidal Volume (rTV) and Seconds Since Last Breath (SSLB) that are all delivered continuously and in real time.
2022: Linshom Medical awarded $2.4M SBIR Fasttrack award from NIH (NHLBI) - World News Report - EIN Presswire_ Biohealth Innovation
2025: Linshom Medical Announces FDA Clearance of the Company’s 2nd Generation Respiratory Sensor_Biohealth Innovation